BTK-HEMMER

European patent · EP4087845 · In force

Register entry

Publication number
EP4087845
Application number
EP20910897
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 29, 2020
Published
Nov 16, 2022
Granted
Oct 21, 2026
Protection ends at the latest
Dec 28, 2040
Next annual fee due
Dec 31, 2026
IPC classes
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Priority
WO PCT/CN2020/070034 02.01.2020
WO PCT/CN2020/134601 08.12.2020
PCT application
PCT/CN2020/140517 29.12.2020
PCT publication
WO2021/136219 08.07.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 21, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.10.2026

Parties

Holder

Dizal Pharmaceutical Co., Ltd.

No. 199 Liangjing Road Zhangjiang Hi-Tech Park, Shanghai 201203, CN

Inventor

ZHOU, Quan

Shanghai 201203, CN

SHEN, Changmao

Shanghai 201203, CN

CHEN, Xiang

Shanghai 201203, CN

LIU, Wengeng

Shanghai 201203, CN

WANG, Rumin

Shanghai 201203, CN

ZENG, Qingbei

Shanghai 201203, CN

TSUI, Honchung

Shanghai 201203, CN

YANG, Zhenfan

Shanghai 201203, CN

ZHANG, Xiaolin

Shanghai 201203, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.